Ikeda J, Kunimoto H, Saito Y, Tsujimoto S-I, Takeuchi M, Miura A, Kurosawa T, Murakami K, Kato I, Funakoshi-Tago M, Yokoyama A, Shiba N, Adachi S, Tomizawa D, Tamura T, Ito S, Nakajima H. Metabolic reprogramming by PRDM16 drives cytarabine resistance in acute myeloid leukemia. Haematologica 2025;110(11):2647-2660; https://doi.org/10.3324/haematol.2024.287265.